TENT2 and neoplasm: We first tested the gld-3(0) nos-3(0) animals, with gld-3(0) reducing GLD-2 pathway activity and nos-3(0) reducing GLD-1 pathway activity, which form a robust GLP-1/Notch signaling independent tumour [34].